A case study applying a novel approach to estimate the social impact of a medical innovation - the use of secukinumab for psoriatic arthritis in Germany.
Sebastian F W HimmlerMalina MuellerBintu SherifDennis OstwaldPublished in: Expert review of pharmacoeconomics & outcomes research (2019)
The improvements in PsA-related functional impairment could lead to sizable productivity effects within the economy.